BackUniversal Ibogaine Overview

Universal Ibogaine Intangible Assets

Latest intangible assets for IBOGF: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer trimmed avg / median

Loading

Universal Ibogaine Intangible Assets History

Loading

Universal Ibogaine vs. peers: Intangible Assets Comparison

Loading

Universal Ibogaine Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Universal Ibogaine (IBOGF) FAQ

Universal Ibogaine (IBOGF) currently reports a intangible assets of $0 as of April 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Universal Ibogaine's intangible assets history and peer comparisons.

Universal Ibogaine's intangible assets changed from $0 to $0 (period ending April 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Universal Ibogaine reported $0 in intangible assets as of April 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Universal Ibogaine, and consider following IBOGF for alerts when major investors trade the stock.

Universal Ibogaine is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IBOGF with unrelated industries.